Melanoma Journal Articles for June 2019

Journal of Cancer Survivorship

The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors

Julia Lai-Kwon, Chloe Khoo, Serigne Lo, Donna Milne, Mustafa Mohamed, Jeanette Raleigh, Kortnye Smith, Karolina Lisy, Shahneen Sandhu, Michael Jefford

Original Research

First Online: 04 June 2019


The lancet

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial

Prof Georgina V Long, PhD , Robyn P M Saw, MS, Serigne Lo, PhD, Prof Omgo E Nieweg, PhD, Kerwin F Shannon, MBBS, Maria Gonzalez, MHlthSc, et al.

Published:June 03, 2019DOI:

New England Journal of Medicine

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

Caroline Robert, M.D., Ph.D., Jean J. Grob, M.D., Ph.D., Daniil Stroyakovskiy, M.D., Boguslawa Karaszewska, M.D., Axel Hauschild, M.D., Evgeny Levchenko, M.D., Vanna Chiarion Sileni, M.D., Jacob Schachter, M.D., Claus Garbe, M.D., Igor Bondarenko, M.D., Ph.D., Helen Gogas, M.D., Mario Mandalá, M.D., et al.


June 4, 2019
DOI: 10.1056/NEJMoa1904059

Dove Press

Photothermal effects of NaYF4:Yb,Er@PE3@Fe3O4superparamagnetic nanoprobes in the treatment of melanoma

Authors Wang X, Kang C, Pan Y, Jiang R

Received 27 January 2019

Accepted for publication 1 May 2019

Published 10 June 2019 Volume 2019:14 Pages 4319—4331


Cancer Research

Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down?regulating PI3K/AKT pathway

Chenjie WangXiaoran WangJiahui LiuZheqian HuangChaoyang LiYing LiuXuan SangLiu YangShoubi WangYaru SuChengxiu LiuYizhi LiuZhichong Wang

First published: 07 June 2019,


Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations

Getachew BoruColleen M. CebullaKlarke M. SampleJames B. MassengillFrederick H. DavidorfMohamed H. Abdel-Rahman

Investigative Ophthalmology & Visual Science June 2019, Vol.60, 2474-2480. doi:10.1167/iovs.18-26452

Dove Press

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression

Authors Wang M, Xu Y, Wen GZ, Wang Q, Yuan SM

Received 13 February 2019

Accepted for publication 26 April 2019

Published 13 June 2019 Volume 2019:12 Pages 4643—4654


Dove Press

Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354

Authors Liu C, Chen W, Chen ZYan Y, Wang Q, Xie H, Chen X, Wang A, Tang S, Zhou J

Received 5 March 2019

Accepted for publication 27 April 2019

Published 14 June 2019 Volume 2019:12 Pages 4655—4663


The Lancet

Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis

Emily A Merkel, MD, Lauren S Mohan, MSc, Katherine Shi, BS, Elnaz Panah, MD, Bin Zhang, MS, Pedram Gerami, MD 

Published:June 13, 2019DOI:

The Lancet

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

Prof Georgina V Long, PhD, Prof Reinhard Dummer, MD, Omid Hamid, MD, Prof Thomas F Gajewski, MD, Christian Caglevic, MD, Prof Stephane Dalle, MD, et al.

Published:June 17, 2019DOI:

SN Applied Sciences

Feature extraction from dermoscopy images for melanoma diagnosis

Sharmin MajumderMuhammad Ahsan Ullah

  • Research Article
  • First Online: 20 June 2019

Cancer Medicine

Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study

Antonio Tejera?Vaquerizo, Simone Ribero, Susana Puig, Aram Boada, Sabela Paradela, David Moreno?Ramírez, Javier Cañueto, Blanca de Unamuno, Ana Brinca,

First published: 18 June 2019

Cancer medicine

Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study

Heather S. Feigelson, John D. Powers, Mayanka Kumar, Nikki M. Carroll, Arun Pathy, Debra P. Ritzwoller

First published: 19 June 2019

Original Investigation

June 26, 2019

Comparison of Survival Between Patients With Single vs Multiple Primary Cutaneous Melanomas

Mary-Ann El Sharouni, MD1Arjen J. Witkamp, MD, PhD2Vigfús Sigurdsson, MD, PhD1; et alPaul J. van Diest, MD, PhD3

JAMA Dermatol. Published online June 26, 2019. doi:10.1001/jamadermatol.2019.1134

Anatomy and Pathology/Oncology  |   June 2019

Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition

Ikram El ZaouiMaya BucherDonata RimoldiMichael NicolasGurkan KayaRosanna Pescini GobertNicola BedoniAnn SchalenbourgEzziat SakinaLeonidas ZografosSerge LeyvrazNicolo RiggiCarlo RivoltaAlexandre P. Moulin

Investigative Ophthalmology & Visual Science June 2019, Vol.60, 2764-2772. doi:10.1167/iovs.18-26508

British Journal of Dermatology

Original Article

Full Access

The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population?based matched cohort study in Korea

H.S. Kim, H.J. Kim, E.S. Hong, K.B. Kim, J.D. Lee, T.U. Kang, H.S. Ahn

First published: 24 June 2019

Cell Reports

Volume 27, Issue 12, 18 June 2019, Pages 3573-3586.e7

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

BengtPhung18MaciejCie?la28AdrianaSanna1NicolaGuzzi2GiuliaBeneventi2PhuongCao Thi Ngoc2MartinLauss1RitaCabrita1EugeniaCordero3AnaBosch1FridaRosengren1JariHäkkinen1KlausGriewank4AnnettePaschen4KatjaHarbst1HåkanOlsson1ChristianIngvar5AnaCarneiro16GöranJönsson191011


2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder